Regional variation in Aswan for CJC-1295 sourcing centres on shipping timelines, customs handling, and vendor familiarity with Aswan delivery — the COA standards are identical across all of Aswan. Research-grade CJC-1295 reaches Aswan researchers through the same worldwide supply routes that serve the broader research community — the barriers to access within Aswan are largely a matter of information rather than physical or regulatory for most Aswan researchers. Aswan's position in the research peptide supply chain is primarily as a destination market served by international vendors — the COA and storage requirements are no different from any other market globally. Apply the framework in this guide to evaluate CJC-1295 vendors with confidence — the methodology applies wherever in Aswan you are conducting research.
The Science Behind CJC-1295
The oral bioavailability of MK-677 (Ibutamoren) distinguishes it from other compounds in the GHS class and has research design implications for Aswan researchers. As an oral GHS, MK-677 avoids the technical requirements of injectable administration, making it more accessible for longer-term studies in non-specialized settings. Its half-life of approximately 24 hours produces a sustained GH elevation pattern, different from the acute pulsatile stimulation of injectable GHRPs. Aswan researchers selecting between CJC-1295 options should consider whether acute pulsatile GH stimulation or sustained GH elevation is more relevant to their specific research question.
Aswan researchers sourcing CJC-1295 should factor in typical shipping timelines: international peptide shipments to Aswan typically take roughly 5 to 15 working days depending on vendor location and shipping method. The COA verification step that Aswan researchers sometimes omit is checking that the certificate batch reference matches the actual vial you receive — a COA is only meaningful when it is traceable to your particular vial. Experienced vendors publish their Aswan shipping history on their websites or in community discussions — look for genuine Aswan shipping experience rather than generic 'international shipping available' statements. Avoid starting time-sensitive research protocols without sufficient product already in storage given the inherent unpredictability of international delivery.
CJC-1295: Storage, Reconstitution & Protocols
CJC-1295 is a research compound unapproved for therapeutic human use — storage: lyophilised at −20°C, reconstituted solution refrigerated at 2-8°C and used within 30 days of reconstitution with bacteriostatic water. Vendor-provided endotoxin testing is a prerequisite for injectable research use — verify this is present in the batch-matched COA before any injectable application. From a handling safety perspective, CJC-1295 presents the standard considerations for research-grade peptides — sterile technique, correct cold-chain storage, and COA-verified product are the primary factors.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
